Macro Biologics Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $16.7M

  • Investors
  • 6

Macro Biologics General Information

Description

Operator of a biotechnology company intended to prevent and treat life-threatening infections. The company uses long-chain amino acid block biological copolymers, broadly antimicrobial against gram-positive and gram-negative bacteria, including antibiotic-resistant strains, as well as yeast, enabling medical care professionals to prevent infection during surgery.

Contact Information

Website
www.macrobiologics.com
Formerly Known As
Amicrobe
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3142 Tiger Run Court
  • Suite 101
  • Carlsbad, CA 92010
  • United States
+1 (888)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • 3142 Tiger Run Court
  • Suite 101
  • Carlsbad, CA 92010
  • United States
+1 (888)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Macro Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series D) 24-Apr-2024 $16.7M Completed Generating Revenue
5. Grant 22-Jun-2020 Completed Generating Revenue
4. Later Stage VC 12-Feb-2020 Completed Generating Revenue
3. Later Stage VC (Series C) 20-Sep-2013 Completed Clinical Trials - General
2. Grant 01-Jan-2012 $161K $1000K Completed Clinical Trials - General
1. Early Stage VC (Series B) 18-Feb-2011 $1000K $1000K Completed Clinical Trials - General
To view Macro Biologics’s complete valuation and funding history, request access »

Macro Biologics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D
Series C
Series B 600,000 $0.000100 $0.54 $6.67 $6.67 1x $6.67 7.42%
Series A 800,000 $0.000100 $0 $0.01 $7.04 1408x $0.01 9.89%
To view Macro Biologics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Macro Biologics Patents

  • 41

    Total Documents Applications and Grants

  • Total Patents Families

  • 23

    Granted

  • 10

    Pending

  • Expiring in next 12 mo

Macro Biologics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3179706-A1 Compositions and uses of locally applied synthetic amino acid polymers for prevention and treatment of viral infections Pending 08-Apr-2020
EP-4132468-A1 Compositions and uses of locally applied synthetic amino acid polymers for prevention and treatment of viral infections Pending 08-Apr-2020
EP-4132468-A4 Compositions and uses of locally applied synthetic amino acid polymers for prevention and treatment of viral infections Pending 08-Apr-2020
WO-2021207164-A1 Compositions and uses of locally applied synthetic amino acid polymers for prevention and treatment of viral infections Inactive 08-Apr-2020
CA-3058901-A1 Compositions and uses of locally applied antimicrobials with enhanced performance and safety Active 06-Apr-2017 A61P31/04
To view Macro Biologics’s complete patent history, request access »

Macro Biologics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Macro Biologics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beiersdorf Venture Capital Corporate Venture Capital Minority
Impact Foundation Impact Investing Minority
Angel (individual) Minority
Angel (individual) Minority
CARB-X University
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Macro Biologics FAQs

  • When was Macro Biologics founded?

    Macro Biologics was founded in 2011.

  • Where is Macro Biologics headquartered?

    Macro Biologics is headquartered in Carlsbad, CA.

  • What is the size of Macro Biologics?

    Macro Biologics has 9 total employees.

  • What industry is Macro Biologics in?

    Macro Biologics’s primary industry is Biotechnology.

  • Is Macro Biologics a private or public company?

    Macro Biologics is a Private company.

  • What is the current valuation of Macro Biologics?

    The current valuation of Macro Biologics is .

  • What is Macro Biologics’s current revenue?

    The current revenue for Macro Biologics is .

  • How much funding has Macro Biologics raised over time?

    Macro Biologics has raised $25.2M.

  • Who are Macro Biologics’s investors?

    Beiersdorf Venture Capital, Impact Foundation, , , and CARB-X are 5 of 6 investors who have invested in Macro Biologics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process